1 July 2026
DLA Piper advises on Hong Kong IPO and H share listing of Guangdong True Health Medical Technology Development Co., Ltd.
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Sherlyn Lau Lead | DLA Piper | Partner | Capital Markets and Corporate Finance | APAC |
| Iris Yuen | DLA Piper | Counsel | Not stated | Not stated |
| Jacob Zhao | DLA Piper | Counsel | Not stated | Not stated |
| Jiefei Yao | DLA Piper | Other | Not stated | Not stated |
| Hannah Wong | DLA Piper | Other | Not stated | Not stated |
| Wendy Ho | DLA Piper | Other | Not stated | Not stated |
| Claudia Lau | DLA Piper | Other | Not stated | Not stated |
| Marcus Xing-Li | DLA Piper | Other | Not stated | Not stated |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- HKD 449m (over HKD449 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Guangdong True Health Medical Technology Development Co., Ltd. (Issuer)
China International Capital Corporation Hong Kong Securities Limited (Underwriters)
DBS Asia Capital Limited (Underwriters)